80 related articles for article (PubMed ID: 30220152)
1. [Efficacy and safety of licartin with repeated administration in treatment of HCC patients after liver transplantation].
Li J; Qin L; Ding EC; Shen J; Li JP
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(33):2645-2649. PubMed ID: 30220152
[No Abstract] [Full Text] [Related]
2. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.
Xu J; Shen ZY; Chen XG; Zhang Q; Bian HJ; Zhu P; Xu HY; Song F; Yang XM; Mi L; Zhao QC; Tian R; Feng Q; Zhang SH; Li Y; Jiang JL; Li L; Yu XL; Zhang Z; Chen ZN
Hepatology; 2007 Feb; 45(2):269-76. PubMed ID: 17256759
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma.
Dai D; Xu W; Liu J; Zhu L; Zhu X; Ma X
Exp Ther Med; 2013 Dec; 6(6):1417-1422. PubMed ID: 24250722
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
Li Z; Zhou JX; Ren JZ; Zhang WJ; Han XW
Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):728-33. PubMed ID: 24331628
[TBL] [Abstract][Full Text] [Related]
5. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
[TBL] [Abstract][Full Text] [Related]
9. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of anatomic and non-anatomic hepatectomy for single small hepatocellular carcinoma with microvascular invasion].
Liu Y; Dai Y; Zhang XX; Li SM; Liu RJ; Fan H
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1937-1940. PubMed ID: 29996286
[No Abstract] [Full Text] [Related]
11. Hepatocellular Carcinoma Patients May Benefit From Postoperative Huaier Aqueous Extract After Liver Transplantation.
Lei JY; Yan LN; Zhu JQ; Wang WT
Transplant Proc; 2015 Dec; 47(10):2920-4. PubMed ID: 26707314
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
13. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of sorafenib in the prevention and treatment of hepatocellular carcinoma recurrences after liver transplantation].
Hu AB; He XS; Tai Q; Zhu XF; Ma Y; Wang DP; Wang GD; Wu LW; Ju WQ; Huang JF
Zhonghua Yi Xue Za Zhi; 2012 May; 92(18):1264-7. PubMed ID: 22883065
[TBL] [Abstract][Full Text] [Related]
15. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
Li SP; Wu LQ
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
[TBL] [Abstract][Full Text] [Related]
16. Study of Preoperative Antiviral Treatment of Patients with HCC Negative for HBV-DNA.
Liu XF; Zhang T; Tang K; Sui LL; Xu G; Liu Q
Anticancer Res; 2017 Aug; 37(8):4701-4706. PubMed ID: 28739774
[TBL] [Abstract][Full Text] [Related]
17. [Liver transplantation for hepatocellular carcinoma: a report of 60 cases].
Chen GH; Yang Y; Lu MQ; Cai CJ; He XS; Zhu XF; Xu C; Li H; Huang JF
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):413-6. PubMed ID: 15144669
[TBL] [Abstract][Full Text] [Related]
18. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
19. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
20. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]